Ono Pharmaceutical CEOs: 4 Presidents Since 2006

Revenue and CEOs4 CEOs
Ono Pharmaceutical
CEOs and long-term results
FY2026
Consolidated
Revenue
¥515.8 billion
Net margin
13.5%
KorekaneSagaraTakino
Revenue¥5.1 billionRevenue¥17.1 billionRevenue¥148.7 billionRevenue¥160.3 billionRevenue¥515.8 billionNet margin3.9%Net margin2.3%Net margin24.3%Net margin15.6%Net margin13.5%1966/31971/31976/31981/31986/31991/31996/32001/32006/32011/32016/32021/32026/3
Revenue¥5.1 billionRevenue¥148.7 billionRevenue¥515.8 billionNet margin3.9%Net margin24.3%Net margin13.5%1966/31976/31986/31996/32006/32016/32026/3
Tenure timeline
Presidents4